4//SEC Filing
PRINS RICHARD K 4
Accession 0001415889-24-026756
CIK 0001297184other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 6:55 PM ET
Size
10.1 KB
Accession
0001415889-24-026756
Insider Transaction Report
Form 4
PRINS RICHARD K
Director
Transactions
- Sale
Common Stock
2024-11-12$48.80/sh−5,000$243,986→ 31,471 total - Exercise/Conversion
Common Stock
2024-11-12$16.69/sh+2,500$41,725→ 36,471 total - Gift
Common Stock
2024-11-12−1,000→ 30,471 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-12−2,500→ 4,179 totalExercise: $16.69Exp: 2026-06-07→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.797 to $48.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Shares subject to the option are fully vested and immediately exercisable.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001047579
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 6:55 PM ET
- Size
- 10.1 KB